BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/9/2026 7:30:47 AM | Browse: 1 | Download: 0
 |
Received |
|
2025-09-30 02:22 |
|
Peer-Review Started |
|
2025-09-30 02:22 |
|
First Decision by Editorial Office Director |
|
2025-10-17 08:37 |
|
Return for Revision |
|
2025-10-17 08:37 |
|
Revised |
|
2025-10-30 15:09 |
|
Publication Fee Transferred |
|
2025-11-06 12:24 |
|
Second Decision by Editor |
|
2025-12-15 02:40 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-15 08:31 |
|
Articles in Press |
|
2025-12-15 08:31 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-02-02 07:11 |
|
Publish the Manuscript Online |
|
2026-02-09 07:30 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Retrospective Study |
| Article Title |
Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Vijay K Trehan, Safal Safal, Siddhant Trehan, Sanjeev Kathuria and Preeti S Vani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Preeti S Vani, Medical Division, Sahajanand Laser Technology Ltd., AQ, Gandhinagar 382016, Gujarat, India. clinical@sltl.com |
| Key Words |
Drug-eluting stents; Coronary artery disease; Percutaneous coronary intervention; NeoHexa sirolimus-eluting stent; Major adverse cardiac events; Target lesion revascularization; Target vessel revascularization; Cardiac mortality |
| Core Tip |
This retrospective study provides valuable long-term real-world evidence on the safety and efficacy of the NeoHexa drug-eluting stent in an all-comer, real world patient population. Over an average follow-up of more than five years, the study observed low rates of major adverse cardiac events (4.32%), including minimal target lesion/target vessel revascularization. The findings highlight the stent’s durable performance, even in high-risk and complex patients across routine and pandemic-era clinical settings. |
| Publish Date |
2026-02-09 07:30 |
| Citation |
Trehan VK, Safal S, Trehan S, Kathuria S, Vani PS. Five-year mean follow-up of NeoHexa sirolimus eluting coronary stent: A retrospective evaluation of long-term safety and efficacy. World J Cardiol 2026; 18(2): 114636 |
| URL |
https://www.wjgnet.com/1949-8462/full/v18/i2/114636.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v18.i2.114636 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
